Global Plasma Therapy Market Size By End User(Hospitals & Clinics, and Research Institutes), By Application(Cardiac Muscle Injury, Dental, Nerve Injury, Dermatology), By Source(Autologous and Allogenic), By Type(Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin), By Geographic Scope And Foreca

Plasma Therapy Market Size And Forecast

Plasma Therapy Market size was valued at USD 224.20 Million in 2020 and is projected to reach USD 634.27 Million by 2028, growing at a CAGR of 14.05% from 2021 to 2028.

The rise in the number of patients suffering from orthopedic disorders is anticipated to drive the growth of the global plasma therapy market.  The Global Plasma Therapy Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Plasma Therapy Market Definition

The blood consists of red blood cells, platelets, plasma, and white blood cells. Almost 55% of the total blood volume is made up of plasma. The plasma carries important hormones, proteins, and nutrients to different parts of the body. The main purpose of plasma therapy is to transfer the immunity of a healthy person to a patient. The plasma usually contains a high number of antibodies and thus helps in curing the disease.

Global Plasma Therapy Market Overview

The growth of the global plasma therapy market is being driven by rising incidences of sports injuries. The rise in the number of androgenic alopecia patients worldwide has led to increasing demand for plasma therapy. The plasma therapy market is flourishing at a rapid pace owing to the increasing use of platelet-rich plasma in various therapeutic areas. The increasing prevalence of arthritis is boosting the growth of the global plasma therapy market.

However, some restraints are liming the growth of the global plasma therapy market. The issue related to the lack of reimbursement policies is hampering the growth of the global plasma therapy market. The varying price of plasma therapy is expected to create setbacks for the growth of the global plasma therapy market.

Global Plasma Therapy MarketSegmentation Analysis

The Global Plasma Therapy Market is Segmented Based on End User, Application, Source, Type, And Geography.

Plasma Therapy Market by End User

• Hospitals & Clinics
• Research Institutes

Based on End User, the market is bifurcated into Hospitals & Clinics, and Research Institutes. The hospital segment contributed majorly to the growth of the global plasma therapy market owing to an increase in healthcare spending.

Plasma Therapy Market by Application

• Cardiac Muscle Injury
• Dental
• Nerve Injury
• Dermatology
• Orthopedic
• Others

Based on Application, the market is bifurcated into Cardiac Muscle Injury, Dental, Nerve Injury, Dermatology, Orthopedic, and Others. The dermatology segment is further bifurcated into Plastic Surgery and Androgenic Alopecia. The orthopedic segment is further bifurcated into Arthritis, Chronic Tendinitis, and Bone Repair & Regeneration. The dermatology segment is growing at a rapid pace owing to the increase in the number of cosmetic procedures.

Plasma Therapy Market by Source

• Autologous
• Allogenic

Based on Source, the market is bifurcated into Autologous and Allogenic. The autologous segment dominated the global plasma therapy market owing to the increasing prevalence of orthopedic disorders.

Plasma Therapy Market by Type

• Pure PRP
• Leukocyte-Rich PRP
• Pure Platelet-Rich Fibrin
• Leukocyte-Rich Fibrin

Based on Type, the market is bifurcated into Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, and Leukocyte-Rich Fibrin. The pure PRP segment dominated the global plasma therapy market.

Plasma Therapy Market by Geography

• North America• Europe• Asia Pacific• Rest of the world

Based on regional analysis, the Global Plasma Therapy Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share in the market will be dominated by North America. The dominance of the North American region is credited to the presence of major players in the region.

Key Players

The “Global Plasma Therapy Market” study report will provide a valuable insight with an emphasis on the global market. The major players in the market are

1. Biolife Plasma Services2. Cambryn Biologics LLC3. Biotest4. CSL Ltd.5. Grifols International S.A.6. Kedrion S.P.A.7. LFB SA8. Bio Product Laboratory Ltd. (BPL)9. China Biologic Products, Inc.10. Octapharma

These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

Key Developments

Partnerships, Collaborations and Agreements

• On May 2020, CSL Limited Enters Strategic Partnership With Thermo Fisher Scientific. The strategic partnership was created to help meet the increasing demand for biologic therapies while also accelerating CSL’s broader manufacturing objectives.

Mergers and Acquisitions

• On September 2018, Shire plc has acquired sanaplasma AG, a source plasma collection company headquartered in Switzerland. The acquisition is expected to increase Shire’s access to plasma in the longer term and add to its European plasma collection network, complementing existing core capabilities in plasma supply and manufacturing.

• On April 2020, Akron Biotech has expanded its operations by acquiring a biologics facility in Sarasota, Florida second manufacturing plant. The firm makes cGMP-compliant cytokines that are embedded in numerous clinical and commercial cell therapies and the addition of a second facility is needed to expand capacity to meet the tremendous demand.

Product Launches and Product Expansions

• On November 2018, Bio Products laboratory announces the launch of ALBUMINEX 5% and ALBUMINEX 25%, for the treatment of hypovolemia, ascites, hypoalbuminemia including from burns, acute nephrosis, acute respiratory distress syndrome (ARDS), and cardiopulmonary bypass.

• On July 2019, Baxter International Inc. Launched PrisMax, which is used to treat the kidney injuries.

Report Scope

Top Trending Report

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as a future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any  please connect with our sales team, who will ensure that your requirements are met.